PROMISSORY NOTE


 


	$245,000	Los Angeles, California
	 	April 5, 2012
	 	 


FOR VALUE RECEIVED, Genesis Biopharma,
Inc., a Nevada corporation (“Debtor”), promises to pay to the order of Ayer Capital Partners Master Fund, L.P. (“Lender”),
the principal sum of Two Hundred and Forty Five Thousand Dollars ($245,000).


 


1.Maturity. Debtor shall
repay the unpaid principal balance of the Note on the earlier of (i) the sale of $1,000,000 or more of Debtor’s securities,
or (ii) May 4, 2012 (the “Maturity Date”).


 


2.Interest. This Note
shall interest at a rate of 12% per annum; provided, however, that in the event that Debtor has not repaid this Note in full by
the Maturity Date, this Note shall thereafter bear interest at a rate of 18% per annum from the date of this Note until the Note
is paid in full.


 


3.Prepayment. This Note
may be voluntarily prepaid at any time, in whole, but not in part.


 


4.Payment. Principal and
interest shall be payable in lawful money of the United States and shall be made at 230 California Street, Suite 600, San Francisco,
CA 94111, or at such other place as the Debtor shall have designated to Lender in writing for such purpose.


 


5.Miscellaneous.


 


(a)Debtor hereby waives presentment,
demand, protest, notice of dishonor, diligence and all other notices, any release or discharge arising from any extension of time,
discharge of a prior party, release of any or all of any security given from time to time for this Note, or other cause of release
or discharge other than actual payment in full hereof.


 


(b)Lender shall not be deemed,
by any act or omission, to have waived any of its rights or remedies hereunder unless such waiver is in writing and signed by Lender
and then only to the extent specifically set forth in such writing. A waiver with reference to one event shall not be construed
as continuing or as a bar to or waiver of any right or remedy as to a subsequent event. No delay or omission of Lender to exercise
any right, whether before or after a default hereunder, shall impair any such right or shall be construed to be a waiver of any
right or default, and the acceptance at any time by Lender of any past-due amount shall not be deemed to be a waiver of the right
to require prompt payment when due of any other amounts then or thereafter due and payable.


 


(c)Time is of the essence hereof.
Upon any default hereunder, Lender may exercise all rights and remedies provided for herein and by law or equity, including, but
not limited to, the right to immediate payment in full of this Note.


 


(d)The remedies of Lender as provided
herein, or any one or more of them, or in law or in equity, shall be cumulative and concurrent, and may be pursued singularly,
successively or together at Lender's sole discretion and may be exercised as often as occasion therefor shall occur.


 



    	 



    	 



    

(e)If any provisions of this Note
would require Debtor to pay interest hereon at a rate exceeding the highest rate allowed by applicable law, Debtor shall instead
pay interest under this Note at the highest rate permitted by applicable law.


 


(f)This Note shall be governed
by and construed in accordance with and the laws of the State of California applicable to contracts wholly made and performed in
the State of California.


 


(g)Debtor shall pay all reasonable
costs and expenses, including reasonable attorneys' fees and disbursements, incurred in the collection or enforcement hereof.


 


IN WITNESS WHEREOF, Debtor has executed
this Promissory Note as of the date first above written.


 


 

	 	GENESIS BIOPHARMA, INC., 
a Nevada corporation
	 	 
	 	By: 	 
	 	 	Name:
Title: